(Q34033534)

30 July 2017

1 reference

title

Insulin-like growth factor-I and diabetes. A review (English)

1 reference

30 July 2017

1 reference

Simpson HL

1

1 reference

30 July 2017

Umpleby AM

series ordinal

2

1 reference

30 July 2017

Russell-Jones DL

series ordinal

3

1 reference

30 July 2017

publication date

1 April 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

published in

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

83-95

1 reference

ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The physiology and pharmacology of adipose tissue lipolysis: Its inhibition and implications for the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Studies of acute effects of insulin-like growth factors I and II in human fat cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Regulation of insulin-like growth factor I gene expression by growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Synthesis and Secretion of Insulin-Like Growth Factor and Its Binding Protein by the Perfused Rat Liver: Dependence on Growth Hormone Status*

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects and Binding of Insulin-Like Growth Factor I in the Isolated Soleus Muscle of Lean and Obese Mice: Comparison with Insulin*

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Binding proteins for the insulin-like growth factors: structure, regulation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

ORCADIAN VARIATION OF GH-INDEPENDENT IGF-BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

THE GROWTH HORMONE INDEPENDENT INSULIN-LIKE GROWTH FACTOR-I BINDING PROTEIN BP-28 IS ASSOCIATED WITH SERUM INSULIN-LIKE GROWTH FACTOR-I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN-DEPENDENT DIABETICS

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of insulin-like growth factor-I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Therapeutic potential of insulinlike growth factor i.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Recombinant human insulin‐like growth factor‐I decreases serum lipoprotein(a) concentrations in normal adult men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The effects of growth hormone on protein metabolism in adult growth hormone deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Normalization of the Growth Hormone and Catecholamine Response to Exercise in Juvenile-Onset Diabetic Subjects Treated with a Portable Insulin Infusion Pump

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: a functional role for the portal vascular link

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Characterization of the insulin-antagonistic effect of growth hormone in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The Effects of Repeated Daily Recombinant Human Insulin-like Growth Factor I Administration in Adolescents with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factors. Studies in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980098-1

7 January 2021

10.1016/S1096-6374(98)80098-1

Identifiers

DOI

1 reference

30 July 2017

1 reference